Celltech research cutbacks claim 130 jobs
Thursday 20 November 2003
Celltech is to shed 130 jobs as it gives up on very early-stage drug research.
The UK's largest biotechnology group is shutting a science laboratory in the United States, as well as the proteomics business it acquired as part of Oxford GlycoSciences and has since failed to sell.
Goran Ando, the chief executive, said the closures would free resources for development work on potential new drugs. "Our early stage pipeline is looking very exciting," he said. "We will have entered four products into clinical development during 2003. We believe by focusing resources on research and early development we will maximise the future returns for shareholders."
The US site to be closed is in Seattle and employs 90 people. Scientists there have been looking for genes, proteins and chemicals in the body that might be linked to disease, and which could be targeted by potential new drugs. The laboratory was acquired in 1999 through the merger with ChiroScience. Its work with Amgen, the US biotech giant, to find an osteoporosis treatment will be shifted to Slough.
Celltech said yesterday that two potential bidders for the OGS proteomics business - which is employed by other drug firms to look for human proteins associated with disease - had walked away. It will now close the division with the loss of 40 jobs.
Dr Ando said the proteomics division redundancies could be met out of cash already in the group. The Seattle closure will cost £5.5m, and will free £11.5m of annual spending.
- 1 Paris attacks: Do not call Charlie Hebdo killers 'terrorists', BBC says
- 2 Man who held up 'hire me' sign at Waterloo station returns a year later with 'I'm hiring' sign
- 3 UK weather: Snow to fall in the coming week with sub-zero temperatures to last until early February
- 4 Saudi preacher who 'raped and tortured' his five -year-old daughter to death is released after paying 'blood money'
- 5 The enemy within: People who hear voices in their heads are being encouraged to talk back
Paris attacks: Do not call Charlie Hebdo killers 'terrorists', BBC says
Rowan Atkinson to sell £10 million McLaren 'supercar' he crashed into a tree and a lamppost
UK weather: Snow to fall in the coming week with sub-zero temperatures to last until early February
Saudi preacher who 'raped and tortured' his five -year-old daughter to death is released after paying 'blood money'
Howard 'Mr Nice' Marks reveals he has inoperable cancer: 'I've had an incredible life'
Nigel Farage: NHS might have to be replaced by private health insurance
'We would evict Queen from Buckingham Palace and allocate her council house,' say Greens
French court convicts three over homophobic tweets, in case hailed as a 'significant victory' by LGBT rights campaigners
Greece elections: Syriza and EU on collision course after election win for left-wing party
British Muslim school children suffering a backlash of abuse following Paris attacks
George Galloway condemns 'racist, Islamophobic, hypocritical rag' Charlie Hebdo at freedom of speech rally
iJobs Money & Business
£30000 - £32000 per annum + benefits : Ashdown Group: A highly successful, int...
£18000 - £20000 per annum: Recruitment Genius: This rapidly expanding business...
£25 - 28k + Bonus: Guru Careers: An In-house / Internal Recruiter is needed to...
Negotiable: Recruitment Genius: A Tax Assistant is required to join a leading ...